X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8617) 8617
Publication (797) 797
Book Review (50) 50
Book Chapter (46) 46
Conference Proceeding (22) 22
Dissertation (4) 4
Book / eBook (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (5076) 5076
peptidyl-dipeptidase a - metabolism (4456) 4456
humans (4350) 4350
male (3922) 3922
rats (2493) 2493
index medicus (2448) 2448
female (2380) 2380
peptidyl-dipeptidase a - genetics (1889) 1889
angiotensin (1297) 1297
middle aged (1247) 1247
angiotensin-converting enzyme (1181) 1181
adult (1162) 1162
angiotensin-converting enzyme inhibitors - pharmacology (1081) 1081
biochemistry & molecular biology (1066) 1066
hypertension (1043) 1043
enzymes (1004) 1004
mice (1003) 1003
dipeptidases - metabolism (919) 919
peptidyl-dipeptidase a - blood (910) 910
pharmacology & pharmacy (799) 799
aged (787) 787
angiotensin converting enzyme (760) 760
peripheral vascular disease (751) 751
renin-angiotensin system (739) 739
kinetics (737) 737
expression (734) 734
angiotensin ii - metabolism (706) 706
blood pressure - drug effects (656) 656
blood-pressure (618) 618
blood pressure (601) 601
physiology (585) 585
peptidyl-dipeptidase a (576) 576
genotype (558) 558
polymorphism, genetic (554) 554
rats, sprague-dawley (553) 553
amino acid sequence (550) 550
angiotensin ii (541) 541
cells, cultured (538) 538
system (518) 518
molecular sequence data (513) 513
cardiac & cardiovascular systems (494) 494
rats, wistar (492) 492
endocrinology & metabolism (490) 490
renin-angiotensin system - physiology (488) 488
physiological aspects (463) 463
hydrolysis (454) 454
angiotensin i - metabolism (449) 449
substrate specificity (449) 449
research (444) 444
research article (442) 442
lung - enzymology (439) 439
rabbits (429) 429
time factors (427) 427
renin (424) 424
proteins (411) 411
rna, messenger - metabolism (402) 402
disease models, animal (392) 392
kidney - enzymology (392) 392
cell biology (387) 387
captopril - pharmacology (386) 386
ace (385) 385
inhibition (383) 383
myocardial-infarction (380) 380
analysis (378) 378
gene expression (373) 373
oxidative stress (373) 373
in vitro techniques (370) 370
risk factors (367) 367
renin-angiotensin system - drug effects (366) 366
peptides (363) 363
angiotensin-converting enzyme inhibitors - therapeutic use (360) 360
medicine (358) 358
dose-response relationship, drug (356) 356
metabolism (355) 355
genetic aspects (350) 350
medicine, research & experimental (350) 350
bradykinin (347) 347
ace inhibitors (346) 346
peptidyl-dipeptidase a - chemistry (338) 338
kidney - metabolism (337) 337
captopril (324) 324
peptidyl-dipeptidase a - physiology (323) 323
rats, inbred strains (322) 322
receptor (319) 319
hypertension - drug therapy (318) 318
hypertension - physiopathology (317) 317
immunohistochemistry (316) 316
angiotensin-converting enzyme inhibitors (308) 308
myocardium - metabolism (307) 307
peptide fragments - metabolism (303) 303
cells (301) 301
disease (294) 294
hypertension - metabolism (292) 292
swine (292) 292
rodents (286) 286
adolescent (284) 284
diabetes (283) 283
ace2 (277) 277
article (277) 277
rats, inbred shr (276) 276
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8081) 8081
Russian (176) 176
Chinese (90) 90
Japanese (86) 86
German (54) 54
French (42) 42
Polish (35) 35
Italian (13) 13
Spanish (12) 12
Ukrainian (7) 7
Croatian (5) 5
Czech (5) 5
Hungarian (4) 4
Danish (3) 3
Dutch (3) 3
Portuguese (3) 3
Serbian (2) 2
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 09/2008, Volume 23, Issue 9, pp. 1327 - 1338
The renin–angiotensin system (RAS) is a key regulator of vascular resistance, sodium and water homeostasis and the response to tissue injury. Historically,... 
hepatic fibrosis | angiotensin converting enzyme 2 | renin–angiotensin system | angiotensin (Ang)‐(1–7) | Hepatic fibrosis | Angiotensin converting enzyme 2 | Angiotensin (Ang)-(1-7) | Renin-angiotensin system | angiotensin (Ang)-(1-7) | FIBROSIS DEVELOPMENT | II RECEPTOR ANTAGONIST | ACE-INHIBITOR | CONVERTING ENZYME-INHIBITORS | TYPE-1 RECEPTOR | RENAL HEMODYNAMICS | HEPATIC STELLATE CELLS | PORTAL PRESSURE | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | renin-angiotensin system | ANTIHYPERTENSIVE ACTIONS | Proto-Oncogene Proteins - metabolism | Kinins - metabolism | Peptide Fragments - metabolism | Liver - enzymology | Angiotensin II - metabolism | Receptors, G-Protein-Coupled - metabolism | Angiotensin I | Humans | Liver - metabolism | Liver - physiopathology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Animals | Hypertension, Portal - metabolism | Liver Cirrhosis - metabolism | Peptidyl-Dipeptidase A - metabolism | Angiotensins - metabolism | Renin-Angiotensin System - drug effects | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Liver Diseases - physiopathology | Liver Diseases - metabolism | Kallikreins - metabolism | Renin-Angiotensin System, drug effects | Proto-Oncogene Proteins, metabolism | Angiotensin II Type 1 Receptor Blockers, pharmacology | Kallikreins, metabolism | Liver Cirrhosis, metabolism | Kinins, metabolism | Liver Diseases, physiopathology | Liver, metabolism | Liver Diseases, metabolism | Renin-Angiotensin System | Hypertension, Portal, metabolism | Liver, enzymology | Liver, physiopathology | Receptors, G-Protein-Coupled, metabolism | Angiotensin-Converting Enzyme Inhibitors, pharmacology | Angiotensin II, metabolism | Angiotensins, metabolism | Peptide Fragments, metabolism | Peptidyl-Dipeptidase A, metabolism | Liver diseases | Peptide hormones | Angiotensin converting enzyme | Angiotensin
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2013, Volume 123, Issue 5, pp. 2011 - 2023
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 7/2018, Volume 55, Issue 7, pp. 5847 - 5867
In addition to the classical hormonal (tissue-to-tissue) renin-angiotensin system (RAS), there are a paracrine (cell-to-cell) and an intracrine... 
Neurology | Neuroprotection | Neurosciences | Biomedicine | Neurobiology | Aging | Nuclear receptors | Renin-angiotensin system | Parkinson’s disease | Cell Biology | Dopaminergic | SYSTEM | NADPH OXIDASE | OXIDATIVE STRESS | Parkinson's disease | TYPE-2 RECEPTOR | NEUROSCIENCES | DOPAMINE NEURONS | II TYPE-1 | EXPRESSION | BRAIN | MAS | PARKINSONS-DISEASE | Microglia - metabolism | Mesencephalon - cytology | Reactive Oxygen Species - metabolism | Oxidative Stress | Receptors, G-Protein-Coupled - metabolism | Male | Substantia Nigra - metabolism | Case-Control Studies | Cell Nucleus - metabolism | Dopaminergic Neurons - metabolism | Gene Deletion | Peptidyl-Dipeptidase A - metabolism | Angiotensin II | Proto-Oncogene Proteins - metabolism | Peptide Fragments - metabolism | Paracrine Communication | Signal Transduction | Reactive Nitrogen Species - metabolism | Cells, Cultured | Rodentia | Mitochondria - metabolism | Angiotensin I - metabolism | Haplorhini | Animals | Receptor, Angiotensin, Type 2 - metabolism | Models, Biological | Receptor, Angiotensin, Type 1 - metabolism | Aging - metabolism | Astrocytes - metabolism | Medical research | Nervous system diseases | Neurons | Cell death | Angiotensin | Medicine, Experimental | Superoxide | Neurophysiology | Brain | Neurodegenerative diseases | Substantia nigra | Paracrine signalling | Glial cells | Neuronal-glial interactions | Mitochondria | Renin | Neurodegeneration | Rodents | Intracellular | Pluripotency | Movement disorders | Dopamine receptors
Journal Article
Amino Acids, ISSN 0939-4451, 12/2015, Volume 47, Issue 12, pp. 2541 - 2550
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 01/2013, Volume 18, Issue 1, pp. 19 - 35
Aims: Activation of intrarenal renin–angiotensin system (RAS) has a detrimental effect on the progression of chronic kidney diseases (CKDs), although the... 
Original Research Communications | DIABETES-MELLITUS | CONVERTING ENZYME | EPITHELIAL-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOTHELIAL-CELLS | ENDOCRINOLOGY & METABOLISM | KINASE-C | CHRONIC KIDNEY-DISEASE | CHRONIC RENAL-INSUFFICIENCY | PROXIMAL TUBULE | HYPOCHLORITE-MODIFIED PROTEINS | GLYCATION END-PRODUCTS | Up-Regulation | Epithelial Cells - metabolism | Reactive Oxygen Species - metabolism | Protein Kinase C-alpha - metabolism | Humans | NADPH Oxidases - metabolism | Male | NF-kappa B - metabolism | Advanced Oxidation Protein Products - metabolism | Transcription Factor AP-1 - metabolism | Peptidyl-Dipeptidase A - genetics | Kidney - metabolism | Receptor, Angiotensin, Type 1 - genetics | CD36 Antigens - metabolism | Renin-Angiotensin System | Peptidyl-Dipeptidase A - metabolism | Kidney - physiopathology | Cell Line | Protein Kinase C-alpha - antagonists & inhibitors | Kidney Tubules, Proximal - pathology | Oxidation-Reduction | Signal Transduction | Advanced Oxidation Protein Products - physiology | Rats | Angiotensinogen - metabolism | Renal Insufficiency - metabolism | Rats, Sprague-Dawley | Angiotensinogen - genetics | Animals | Serum Albumin - physiology | Receptor, Angiotensin, Type 1 - metabolism | Mice | Carbazoles - pharmacology | Serum Albumin - metabolism | Chronic kidney failure | Physiological aspects | Albumin | Oxidation-reduction reaction | Development and progression | Research | Renin-angiotensin system
Journal Article
Molecular and Cellular Proteomics, ISSN 1535-9476, 12/2014, Volume 13, Issue 12, pp. 3473 - 3483
Proteomics-based clinical studies represent promising resources for the discovery of novel biomarkers or for unraveling molecular mechanisms underlying... 
HSP90 INHIBITORS | PATHWAYS | CALNEXIN | DISEASE | BIOLOGY | BIOCHEMICAL RESEARCH METHODS | NETWORKS | ENDOPLASMIC-RETICULUM STRESS | ASSOCIATION | IN-VIVO PHOSPHORYLATION | CANCER-THERAPY | Liver - pathology | Phosphorylation | Dipeptidases - metabolism | Protein Disulfide-Isomerases - metabolism | Humans | Middle Aged | Valosin Containing Protein | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Neoplasm Proteins - metabolism | Phosphoproteins - metabolism | Procollagen-Proline Dioxygenase - metabolism | Calnexin - genetics | Heat-Shock Proteins - genetics | Thioredoxins - genetics | Carcinoma, Hepatocellular - genetics | Liver Cirrhosis - metabolism | Aged, 80 and over | Antigens, Neoplasm - metabolism | Cell Cycle Proteins - genetics | Female | Liver Neoplasms - pathology | Thioredoxins - metabolism | Calnexin - metabolism | Proteomics - methods | Neoplasm Proteins - genetics | Liver Cirrhosis - genetics | Antigens, Neoplasm - genetics | Liver Neoplasms - genetics | Signal Transduction | Dipeptidases - genetics | Heat-Shock Proteins - metabolism | Liver - metabolism | Molecular Sequence Annotation | Cell Cycle Proteins - metabolism | Adenosine Triphosphatases - metabolism | Phosphoproteins - genetics | Protein Disulfide-Isomerases - genetics | Procollagen-Proline Dioxygenase - genetics | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Liver Cirrhosis - pathology | Adenosine Triphosphatases - genetics | Aged | Carcinoma, Hepatocellular - metabolism | Research
Journal Article
Biochemical Journal, ISSN 0264-6021, 08/2007, Volume 405, Issue 3, pp. 379 - 395
Journal Article
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 06/2016, Volume 910, pp. 23 - 30
Journal Article
Experimental Physiology, ISSN 0958-0670, 09/2017, Volume 102, Issue 9, pp. 1208 - 1220
The renin-angiotensin system (RAS) has been implicated in the development of metabolic syndrome. We investigated whether the hepatic RAS is modulated by... 
non‐alcoholic fatty liver disease | renin‐angiotensin system | exercise training | renin-angiotensin system | non-alcoholic fatty liver disease | METABOLIC SYNDROME | PHYSIOLOGY | DIET | STEATOSIS | FATTY LIVER-DISEASE | INSULIN-RESISTANCE | NITRIC-OXIDE | NONALCOHOLIC STEATOHEPATITIS | MICE | ADIPOSE-TISSUE | AXIS | Tumor Necrosis Factor-alpha - metabolism | Peptide Fragments - metabolism | Fatty Liver - metabolism | Angiotensin II - metabolism | Rats, Wistar | Fatty Liver - physiopathology | Liver - metabolism | Rats | Male | Renin-Angiotensin System - physiology | Angiotensin I - metabolism | Physical Conditioning, Animal - physiology | Fructose - metabolism | Gluconeogenesis - physiology | Animals | Receptor, Angiotensin, Type 1 - metabolism | Peptidyl-Dipeptidase A - metabolism | Liver - physiology | Interleukin-6 - metabolism | Lipid Metabolism - physiology | Glucose metabolism | Medical research | Enzymes | Liver diseases | Glycogen | Liver | Angiotensin | Physiological aspects | Medicine, Experimental | Renin-angiotensin system | Fructose | Drinking behavior | Metabolism | Steatosis | Interleukin 6 | Fatty liver | Renin | Body mass | Tumor necrosis factor | Peptidyl-dipeptidase A | Rodents | Lipid metabolism | Angiotensin II | ACE inhibitors | Fitness training programs | Metabolic disorders | Gluconeogenesis | Tumors
Journal Article
Scientific Reports, ISSN 2045-2322, 07/2015, Volume 5, Issue 1, p. 11162
Journal Article
Circulation, ISSN 0009-7322, 02/2010, Volume 121, Issue 4, pp. 519 - 528
Journal Article